Terns Pharmaceuticals Inc (TERN)

NASDAQ
2.27
0.00(0.00%)
After Hours
2.27
0.00(0.00%)
- Real-time Data
  • Volume:
    1,446,928
  • Day's Range:
    2.18 - 2.39
  • 52 wk Range:
    1.45 - 13.77

TERN Overview

Prev. Close
2.27
Day's Range
2.18-2.39
Revenue
1M
Open
2.3
52 wk Range
1.45-13.77
EPS
-2.01
Volume
1,446,928
Market Cap
56.12M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
155,551
P/E Ratio
-
Beta
-
1-Year Change
-83.05%
Shares Outstanding
25,279,271
Next Earnings Date
Aug 16, 2022
What is your sentiment on Terns Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Terns Pharmaceuticals Inc Company Profile

Terns Pharmaceuticals Inc Company Profile

Employees
0

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyBuyStrong Sell
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Sell
SummaryStrong SellSellStrong BuyStrong BuyStrong Sell